期刊文献+

硫酸乙酰肝素蛋白聚糖对C_3H小鼠乳腺癌移植瘤的抑制作用及其机制 被引量:14

Inhibitory effects of heparan sulfate proteoglycan on transplanted breast cancer in C_3H mice
暂未订购
导出
摘要 目的观察硫酸乙酰肝素蛋白聚糖(HSPG)对C3H小鼠乳腺癌移植瘤的抑制作用及其机制。方法建立肿瘤模型并随机分为5组:生理盐水组、HSPG组(5、10、50mg.kg-1)及阳性对照组,各组动物自模型建立d2开始腹腔注射给药治疗22d并观察记录肿瘤体积。d24处死动物,称量肿瘤重量,计算胸腺指数及脾指数,使用原位凋亡检测法(TUNEL)检测HSPG对肿瘤细胞凋亡的影响,免疫组化检测血管内皮生长因子(VEGF)的表达。结果HSPG可明显抑制肿瘤生长,而不降低胸腺指数和脾指数。TUNEL结果HSPG组肿瘤组织中出现大量蓝黑色凋亡细胞,且明显多于生理盐水组,HSPG组肿瘤组织的VEGF的表达明显降低。结论HSPG对C3H小鼠移植性乳腺癌生长具有明显的抑制作用,其机制可能与诱导肿瘤细胞凋亡及抑制VEGF表达有关。 Aim To observe the anti-tumor activity and the mechanism of heparan sulfate proteoglycan (HSPG) on C3H mice transplanted tumors. Methods Tumor model was established and randomly divided into five groups. HSPG groups (5, 10, 50 mg · kg^-1), positive group and control group, intraperitoneal injection was performed once a day for 22 days and the volume of tumors was measured. Mice were treated on 24th day, then tumor weight was examined, thymus index, and spleen index were calculated, the apoptosis was determined by TdT-mediated Dutp nick end labeling (TUNEL) assay in situ, the expression of vascular endothelial growth factor (VEGF) was detec- ted by immunohistochemistry. Results The tumor volume in HSPG groups was reduced without the decrease of thymus index, spleen index. TUNEL assay in situ sh HSPG groups cantly group. owed numerous heavy blue apoptosis cells in the groups significantly higher than in control The tumors in HSPG groups showed signifilower VEGF expression than those in control Conclusion HSPG had significant anti-tumor effects on C3H mice transplantable breast cancer. The mechanisms may be associated with the effects of inducing tumor cell apoptosis and inhibiting the VEGF expression.
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第6期744-748,共5页 Chinese Pharmacological Bulletin
基金 安徽省人才开发资金资助项目(No2002Z023)
关键词 硫酸乙酰肝素蛋白聚糖 C3H小鼠 乳腺癌 抗肿瘤 HSPG C3 H mice breast cancer anti-tumor
  • 相关文献

参考文献16

  • 1Bernfield M, Gotte M, Park P W, et al. Functions of cell surface heparan sulfate proteoglycans [ J ]. Annu Rev Biochem 1999,68 : 729 - 77.
  • 2Fugedi P. The potential of the molecular diversity of heparin and heparan sulfate for drug development [ J ]. Mini Rev Med Chem, 2003,3(7 ) :659 -67.
  • 3刘浩,童旭辉,马连华,许诤,崔小岱,蒋志文.C_3H非自发性小鼠乳腺癌模型的建立[J].中国药理学通报,2005,21(11):1396-1398. 被引量:9
  • 4Toi M, Hoshina S, Takayanagi T,Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer[J]. Jpn J Cancer Res, 1994,85(10) :1045 -9.
  • 5Tumova S, Woods A, Couchman J R. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions [ J ]. Ira J Biochem Cell Biol, 2000,32(3 ):269-88.
  • 6Ferro V, Dredge K, Liu L, et al. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis [ J ]. Semin Thromb Hemost, 2007, 33(5) :557 -68.
  • 7Basche M, Gustafson D L, Holden S N, et al. A phase Ⅰ biological and pharmacologic study of the heparanase inhibitor PI - 88 in patients with advanced solid tumors[ J]. Clin Cancer Res,2006,12 (18) :5471 -80.
  • 8Zhang Y, Li L, Wang Y, et al. Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma [ J ]. Biochem Biophys Res Commun,2007,355( 1 ) : 124 -9.
  • 9Zhu Z, Friess H, Kleeff J, et al. Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer[J]. Am J Surg, 2002,184( 1 ) :78 -83.
  • 10Xiang Y Y, Ladeda V, Filmus J. Glypican-3 expression is silenced in human breast cancer[J]. Oncogene, 2001,2,0(50) :7408 - 12.

二级参考文献27

  • 1施新猷.现代医用实验动物学[M].北京:人民军医出版社,2000.254-9.
  • 2高进 张静波.肿瘤学基础与研究方法[M].北京:人民卫生出版社,1998.14-6.
  • 3Couldrey C,Green J E.Metastases:the glycan connection[J].Breast Cancer Res,2000,2:321-3.
  • 4Seberger P J,Chaney W G.Control of metastasis by Asn-linked,beta1,6 branched oligosaccharides in mouse mammary cancer cells[J].Glycobiology,1999,9(3):235-41.
  • 5Handerson T,Camp R,Harigopal M,et al.Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma[J].Clin Cancer Res,2005,11(8):2969-73.
  • 6Hiraizumi S,Takasaki S,Ohuchi N,et al.Altered glycosylation of membrane glycoproteins associated with human mammary carcinoma[J].Jpn J Cancer Res,1992,83(10):1063-72.
  • 7Vrdoljak D V,Knezevic F,Ramljak V.The relation between tumor marker Ca 15~3 and metastases in interpectoral lymph nodes in breast cancer patients[J].Saudi Med J,2006,27(4):460-2.
  • 8Fernandes B,Sagman U,Auger M,et al.Beta 1~6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia[J].Cancer Res,1991,51(2):718-23.
  • 9Burchell J M,Mungul A,Taylor-Papadimitriou J.O-Linked glycosylation in the mammary gland:changes that occur during malignancy[J].J Mammary Gland Biol Neoplasia,2001,6(3):355-64.
  • 10Lloyd K O,Burchell J,Kudryashov V,et al.Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines.Demonstration of simpler and fewer glycan chains in tumor cells[J].J Biol Chem,1996,271(52):33325-34.

共引文献15

同被引文献115

引证文献14

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部